Sign inJoin waitlistJoin the waitlist

Christopher Azzoli

Director of Thoracic Oncology · Rhode Island Hospital/Brown University Health

Credentials: · · · · ·

History

Alpert Medical School
Present

Memorial Sloan Kettering Cancer Center
1999–2001
Johns Hopkins Hospital
1996–1999
Johns Hopkins Univ Sch of Med
1992–1996

Research

American Society of Clinical Oncology treatment of unresectable non-small-cell lung cancer guideline: update 2003
Review · Journal of Clinical Oncology · 2004 · 1,134 citations
EGFR Mutations and ALK Rearrangements Are Associated with Low Response Rates to PD-1 Pathway Blockade in Non-Small Cell Lung Cancer: A Retrospective Analysis
Clinical Cancer Research · 2016 · 1,124 citations
Benefits and harms of CT screening for lung cancer: a systematic review
Systematic review or meta-analysis · JAMA · 2012 · 986 citations

MK
Mark Kris
54 papers
VM
Vincent Miller
29 papers
LK
Lee Krug
25 papers
NR
Naiyer Rizvi
22 papers
William Pao
18 papers
GR
Gregory Riely
16 papers · 2 as a fellow
Valerie Rusch
15 papers
MG
Michelle Ginsberg
13 papers
JC
Jamie Chaft
12 papers · 3 as a fellow
ML
Marc Ladanyi
10 papers
Lecia Sequist
9 papers
MZ
Maureen Zakowski
9 papers

Grants

Prognostic Value of Tumor Hypoxia, as Measured by 18F-FMISO Breath Hold PET/CT
National Cancer Institute · U01
PI · $630K · Sloan-Kettering Inst Can Research
2012–2015

Clinical trials

BrUOG 397: NEO Rad (LOW): Neoadjuvant Low Dose Stereotactic Body Radiotherapy, Ipilimumab and Nivolumab
Principal investigator · Recruiting · Phase 2
Brown University
2021–2026
Erlotinib Re-Challenge for Recurrent EGFR-mutant Lung Cancer in Patients Who Previously Received Adjuvant Erlotinib or Gefitinib
Principal investigator · Terminated · Phase 2
Memorial Sloan Kettering Cancer Center
2010–2012
Docetaxel (Taxotere), Vinorelbine, and Bevacizumab, as Adjuvant Chemotherapy for Patients With Resected Stage I-III Non-small Cell Lung Cancer
Principal investigator · Completed
Memorial Sloan Kettering Cancer Center
2008–2012
Ph I:Bevacizumab + Chemotherapy in Pts w/Malig Pleural Effusion Due to Adv NSCLC
Principal investigator · Completed · Phase 1
Memorial Sloan Kettering Cancer Center
2005–2008